Join the latest episode of the Market Access Podcast, where our host Dr. Stefan Walzer and expert Dr. Ahmed Seddik dissect the complexities of the societal impact of medical innovation. Dr. Ahmed Seddik shares important insights from his journey starting as a dentist in Egypt to his PhD research in health economics and social impact, focusing […]
How can AI revolutionize Market Access, and what does it take to drive successful change in pharma? Tune into the latest episode of MAP, the Market Access Podcast, where our host Dr. Stefan Walzer and Jan Kroschinski, an expert in digital transformation, will delve into change management and AI adoption in pharma. Follow along as […]
We are proud to officially announce that MArS Market Access & Pricing Strategy has been recognized as one of the LEADING EMPLOYERS, ranking us within the top 1% of companies across Germany! With flexibility, innovation and respect defining how we work together, this award reflects our strong company culture. Together we cultivate a thriving environment through: […]
In the latest episode of MAP, the Market Access Podcast, our host Dr. Stefan Walzer sits down with Johan Olsson, a seasoned life sciences investor, to uncover the critical role of market access and reimbursement in early-stage healthcare investments. They explore how early market access planning impacts healthcare startups, investment decisions, and commercialization success. Discover […]
In this episode of MAP, Dr. Stefan Walzer, together with experts Douglas Drake and Adam Skali, unpacks the complexities of how GDPR regulations affect real-world evidence, cross-border studies, and market access in Europe. The discussion highlights data privacy challenges, delays in commercialization, and the future of healthcare data regulation. Learn more about how data privacy […]
Tune in to the latest episode of MAP, the Market Access Podcast, where Dr. Stefan Walzer sits down with Amazon bestselling author Dr. Kasia Hein-Peters to explore the power of structured innovation planning. Get a deeper understanding of how healthcare companies better can balance short-term commercialization with long-term innovation, as well as what roles of […]
Discover the newest episode of MAP, the Market Access Podcast, your go-to podcast for all things Market Access. In todays episode our host Dr. Stefan Walzer dives deep into early market access in commercialization planning, bridging the gap between innovation and market success. Joined by Catherine Bacon, founder of Fingerpost Consulting, the conversation unpacks the […]
This is a repost of a popular episode of MAP – Market Access Podcast, from March 15th 2024. Explore the inspiring journey of Dipti Tankala in this podcast episode as she delves into market access within the pharmaceutical industry. From facing challenges in community pharmacy to leading in oncology market access, Dipti shares valuable insights […]
This is a repost of a popular episode of MAP – Market Access Podcast, from December 15th 2021. Who could be better to tell us the real insights, how the arbitration board works than Prof. Dr. Juergen Wasem, the former head of the AMNOG arbitration board and the current head of the DiGA arbitration board. In this wide ranging […]
This is a repost of a popular episode of MAP – Market Access Podcast, from April 15th 2023. All patients within all populations should have access to high quality medications that improve their health outcomes regardless of race, ethnicity, socio-economic status or any other individual factors, wrote Dr. Utibe R. Essien in an Jama article 2021. But how does […]
This is a repost of a popular episode of MAP – Market Access Podcast, from October 1st 2022. Digital health could improve the efficiency, care and way patients are treated in all health care systems in the next years. Germany has started by implementing digital health applications (“DIGAs”) and is currently on its way to […]
This is a repost of a popular episode of MAP, Market Access Podcast, from 15th of July 2023. Even though there are great accelerators and a lot of innovative product ideas, only very few products actually make it to the market and are commercially successful. What is the reason behind that and even more important […]
Join us on the latest episode of MAP – the Market Access Podcast – where our host Dr. Stefan Walzer, together with special guest Gerdi Strydom, Managing Director at Valid Insight, explore the integration of ESG (Environmental, Social, and Governance) into Health Technology Assessments (HTAs). In this episode, they unpack how healthcare’s carbon footprint and […]
This is a repost of a popular MAP, Market Access Podcast, from 1st of January 2023. Companies launching oncology drugs sometimes struggle with existing reimbursement pathways and negotiations with payers, mainly in Europe, but also in other parts of the world. Evidence generation is the start of every drug development, but especially in oncology the design […]
This is a repost of a popular MAP, Market Access Podcast, from January 2023. A strong evidence package is important as a solid base for health technology assessments and the following price negotiations with health care payers. It is widely agreed, that randomized controlled trials are the gold standard in HTA, but there are also […]
In this repost of MAP, the Market Access Podcast, from 15th of September 2023, you’ll hear from Dr Stefan Walzer and Dr Mike Rosenblatt as they’re discussing the age we are currently in of massive medical innovation, including a lot of new modalities especially in the area of ATMPs, and this insightful conversation highlights some […]
© 2025 All Rights Reserved.
